Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

clear pharmacy - eplerenone - film coated tablet - 25 milligram - aldosterone antagonists

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - eplerenone - film-coated tablet - 25 milligram(s) - aldosterone antagonists; eplerenone

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - eplerenone - film-coated tablet - 50 milligram(s) - aldosterone antagonists; eplerenone

Մալթա - անգլերեն - Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - eplerenone - film-coated tablet - eplerenone 25 mg - diuretics

Մալթա - անգլերեն - Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - eplerenone - film-coated tablet - eplerenone 50 mg - diuretics

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

accord healthcare limited - eplerenone - film coated tablet - 25 milligram - eplerenone - aldosterone antagonists - in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular (cv) mortality and morbidity in stable patients with left ventricular dysfunction (lvef
40 %) and clinical evidence of heart failure after recent myocardial infarction (mi). in addition to standard optimal therapy, to reduce the risk of cardiovascular mortality and morbidity in adult patients with new york heart association (nyha) class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef
30%)

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

accord healthcare limited - eplerenone - film coated tablet - 50 milligram - eplerenone - aldosterone antagonists - eplerenone is indicated: in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular (cv) mortality and morbidity in stable patients with left ventricular dysfunction (lvef
40 %) and clinical evidence of heart failure after recent myocardial infarction (mi). addition to standard optimal therapy, to reduce the risk of cardiovascular mortality and morbidity in adult patients with new york heart association (nyha) class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef
30%)

Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - eplerenone - oral tablet - 25mg

Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - eplerenone - oral tablet - 50mg

Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - eplerenone - oral tablet - 25mg